| scholarly article | Q13442814 |
| P50 | author | Yoichiro Iwakura | Q56564114 |
| Michiko K Oyoshi | Q62752735 | ||
| Christopher N Lewis | Q83641769 | ||
| Raif S. Geha | Q87942862 | ||
| P2093 | author name string | Jacqueline Beaupré | |
| Nicholas Venturelli | |||
| P2860 | cites work | Childhood atopic dermatitis and warts are associated with increased risk of infection: a US population-based study | Q40232619 |
| Smallpox vaccination: Risk considerations for patients with atopic dermatitis | Q44441962 | ||
| Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation | Q45399970 | ||
| Skin inflammation in RelB(-/-) mice leads to defective immunity and impaired clearance of vaccinia virus. | Q45406565 | ||
| IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. | Q46214370 | ||
| IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes | Q46794704 | ||
| Epicutaneous sensitization with superantigen induces allergic skin inflammation. | Q54265045 | ||
| Breaking the (Un)Sound Barrier: Filaggrin Is a Major Gene for Atopic Dermatitis | Q58859847 | ||
| Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice | Q83627641 | ||
| Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches | Q26852335 | ||
| Eczema vaccinatum | Q27009282 | ||
| Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations | Q28249806 | ||
| Interleukin-17 and type 17 helper T cells | Q28256510 | ||
| Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis | Q28303063 | ||
| Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects | Q28511427 | ||
| Two new mutations in linkage group XVI of the house mouse. Flaky tail and varitint-waddler-J | Q28586548 | ||
| Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens | Q30494794 | ||
| Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract. | Q33816405 | ||
| A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. | Q33858072 | ||
| Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis | Q33877517 | ||
| Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen | Q33915290 | ||
| Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis | Q33941199 | ||
| Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense | Q34087551 | ||
| Filaggrin mutations associated with skin and allergic diseases. | Q34223419 | ||
| Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum | Q34294746 | ||
| Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response | Q34781786 | ||
| Viral infections in atopic dermatitis Pathogenic aspects and clinical management | Q35562168 | ||
| IL-10 is critical for Th2 responses in a murine model of allergic dermatitis | Q36001280 | ||
| Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge | Q36023872 | ||
| Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans | Q36399092 | ||
| The Th17 family: flexibility follows function. | Q36713721 | ||
| TSLP acts on infiltrating effector T cells to drive allergic skin inflammation | Q36954478 | ||
| IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice. | Q37036021 | ||
| Toll-like receptor 2 is important for the T(H)1 response to cutaneous sensitization | Q37199491 | ||
| Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response | Q37329533 | ||
| Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice | Q37380666 | ||
| Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. | Q37406747 | ||
| Transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis | Q37649830 | ||
| Thymic stromal lymphopoietin and allergic disease | Q38039733 | ||
| The cutaneous innate immune response in patients with atopic dermatitis. | Q38078473 | ||
| The multifunctional role of filaggrin in allergic skin disease | Q38078474 | ||
| Regulation of Th17 maturation by interleukin 4. | Q38149958 | ||
| Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis | Q38234353 | ||
| Overexpression of IL-1alpha in skin differentially modulates the immune response to scarification with vaccinia virus | Q39706186 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| Vaccinia virus | Q1986297 | ||
| P304 | page(s) | 1511-8.e6 | |
| P577 | publication date | 2015-01-30 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | Filaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virus | |
| P478 | volume | 135 |
| Q38885691 | Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review |
| Q38753828 | Effects of Allergic Sensitization on Antiviral Immunity: Allergen, Virus, and Host Cell Mechanisms |
| Q92406780 | Host-microbial dialogues in atopic dermatitis |
| Q91626434 | Injury, dysbiosis, and filaggrin deficiency drive skin inflammation through keratinocyte IL-1α release |
Search more.